In the interview with Medica trade fair, Tomer Epstein elaborates on some of the new products, which will be presented at this year’s MEDICA.
What kinds of products are being presented at your pavilion each year at MEDICA?
Tomer Epstein: MEDICA is the Israel Export Institute’s main activity for the Life Science industry. We are taking pride in having such a large presence at the fair with Israeli techs. With over 80 companies under our wing, we are offering techs ranging in different areas of healthcare and technology from remote monitoring, diagnostics, over rehabilitation, wound management, pediatrics and many more.
Do they have a relation to the ongoing pandemic situation – if so how?
Epstein: We have an active part in the Israeli company’s business continuity journey. Currently, we are trying to keep business operation the same as before the pandemic if possible. By increasing the activity for commercialization, product awareness and business collaborations for the Israeli companies together with global players such as investment funds, hospitals, insurance companies and distributors we are working towards that goal. We were able to amplify our activity deal flow by 3 times compared to the last years’ time frame. All in the efforts to promote Israeli companies and keep generating valuable business connections.
What are some of the recent innovations in the area of medical devices?
Epstein: Medical devices are shifting towards digital innovation, implementing IT abilities within the devices for more accuracy, better care coordination with physician-patient relation and reduction of care costs. In addition to this growing trend, medical robotics keep pushing forward and taking improvements and deployment in the OR and precise care even further. Some examples would be companies like Sensus Medical for dermatology and oncology treatment, Motorkia for rehabilitation or Sight, that combines hardware and AI for blood diagnostics and complete blood count. Other innovative techs include options for point of care diagnostic and early detection of cancer.